최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기精神身體醫學 = Korean journal of psychosomatic medicine, v.28 no.1, 2020년, pp.20 - 28
이동호 (원광대학교 의과대학 정신건강의학교실) , 이상열 (원광대학교 의과대학 정신건강의학교실) , 류한승 (원광대학교 의과대학 내과학교실) , 최석채 (원광대학교 의과대학 내과학교실) , 양찬모 (원광대학교 의과대학 정신건강의학교실) , 장승호 (원광대학교 의과대학 정신건강의학교실)
Objectives : The aim of this study was to compare psychosocial characteristics of the functional gastrointestinal disorders FGID group, non-FGID group, and control group and determine factors affecting the QOL of patients with FGID. Methods : 135 patients diagnosed with FGID were selected. 79 adults...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
FGID의 대표적인 질환으로는 무엇이 있는가 | 기능성 위장관 질환(Functional gastrointestinal disorder, 이하 FGID)은 구조적인 병리가 보이지 않는 구역, 구토, 복부팽만, 설사, 변비 등의 증상을 보이는 질환이다.1) FGID의 대표적인 질환으로는 과민성 대장 증후군(Irritable bowel syndrome, 이하 IBS), 기능성 변비(Functional constipation, 이하 FC), 기능성 설사(Functional diarrhea), 기능성 흉부 작열감(Functional heart burn, 이하 FH), 기능성 소화불량 (Functional dyspepsia, 이하 FD) 등이 있다.2) | |
로마기준에서 FGID는 어떻게 설명되는가 | FGID는 로마 기준을 통해 발전해 왔다. 2016년에 발표된 로마 기준 IV (Rome IV criteria)의 생물정신사회적 모델(biopsychosocial model)에 따르면 생애 초기의 유전적, 문화적, 환경적 스트레스, 정신사회적 외상, 감정적 고통, 부적응적인인지와 같은 정신사회적인 요소들이 뇌-위장관 축(braingut axis)을 통해 비정상적인 운동, 내장 과민성, 면역기능의변화, 염증, 장내 세균의 변화, 중추 신경계 전달 과정의 변화와 같은 생리학적인 문제들을 일으킨다고 설명하고 있다.3) | |
기능성 위장관 질환이란 무엇인가 | 기능성 위장관 질환(Functional gastrointestinal disorder, 이하 FGID)은 구조적인 병리가 보이지 않는 구역, 구토, 복부팽만, 설사, 변비 등의 증상을 보이는 질환이다.1) FGID의 대표적인 질환으로는 과민성 대장 증후군(Irritable bowel syndrome, 이하 IBS), 기능성 변비(Functional constipation, 이하 FC), 기능성 설사(Functional diarrhea), 기능성 흉부 작열감(Functional heart burn, 이하 FH), 기능성 소화불량 (Functional dyspepsia, 이하 FD) 등이 있다. |
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016;150:1262-1279.
Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med 1999;107:12-19.
Mayer E, Tillisch K, Bradesi S. Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006;24:919-933.
Talley N, Fung L, Gilligan I, McNeil D, Piper D. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause: a case-control study. Gastroenterology 1986;90:886-892.
Karling P, Danielsson A, Adolfsson R, Norrback K. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. J Neurogastroenterol Motil 2007;19:896-904.
Leserman J, Drossman DA. Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms. Trauma, Violence & Abuse 2007;8:331-343.
Kanuri N, Cassell B, Bruce SE, White KS, Gott BM, Gyawali CP, Sayuk GS. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS). J Neurogastroenterol Motil 2016;28:1508-1517.
Norbeck JS, Lindsey AM, Carrieri VL. The development of an instrument to measure social support. Nurs Res 1981;30:264-269.
Lackner J, Brasel A, Quigley BM, Keefer L, Krasner S, Powell C, Katz L, Sitrin M. The ties that bind: perceived social support, stress, and IBS in severely affected patients. J Neurogastroenterol Motil 2010;22:893-900.
Smith BW, Zautra AJ. Vulnerability and resilience in women with arthritis: test of a two-factor model. J Consult Clin Psychol 2008;76:799.
Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a metaanalytic review. Psychosom Med 2003;65:528-533.
Organization WH. WHOQOL study protocol. Geneva: WHO; 1993.
ElSerag H, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-1185.
Kim SW, Jang SH, Ryu HS, Choi SC, Rho SH, Lee SY. A study on the psychosocial characteristics and quality of life in functional gastrointestinal disorders. Korean J Psychosom Med 2019;27:25.
Sung H, Kim J, Park Y, Bai D, Lee S, Ahn H. A study on the reliability and the validity of Korean version of the beck depression inventory-II (K-BDI-II). J Korean Soc Biol Ther Psychiatry 2008;14:201-212.
Yook S, Kim Z. A clinical study on the Korean version of beck anxiety inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185-197.
Kim D, Park SC, Yang H, Oh DH. Reliability and validity of the Korean version of the childhood trauma questionnaireshort form for psychiatric outpatients. Psychiatry Investig 2011;8:305.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess 1988;52:30-41.
Shin J, Lee Y. The effects of social supports on psychosocial well-being of the unemployed. Korean J Soc Welf Res 1999;37:241-269.
Connor KM, Davidson JR. Development of a new resilience scale: The Connor-Davidson resilience scale (CD-RISC). Depress Anxiety 2003;18:76-82.
Baek H, Lee K, Joo E, Lee M, Choi K. Reliability and validity of the Korean version of the Connor-Davidson resilience scale. Psychiatry Investig 2010;7:109.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine 2002;64:258-266.
Han C, Pae C, Patkar AA, Masand PS, Kim KW, Joe S, Jung I. Psychometric properties of the patient health questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics 2009;50:580-585.
Min SK, Lee CI, Kim KI, Suh SY, Kim DK. Development of Korean version of WHO quality of life scale abbreviated version (WHOQOL-BREF). J Korean Neuropsychiatr Assoc 2000;39:571-579.
PintoSanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D, Moayyedi P, Bercik P. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015;110:1038.
Reidy J, Keogh E. Testing the discriminant and convergent validity of the MASQ using a British sample. Pers Individ Differ 1997;23:337-344.
Enns MW, Cox BJ, Parker JD, Guertin JE. Confirmatory factor analysis of the beck anxiety and depression inventories in patients with major depression. J Affect Disord 1998;47:195-200.
Park JH, Rhee P, Kim HS, Lee JH, Kim Y, Kim JJ, Rhee JC, Kang EH, Yu B. Increased ${\beta}$ -adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome. Dig Dis Sci 2005;50:1454-1460.
Geeraerts B, Vandenberghe J, Van Oudenhove L, Gregory LJ, Aziz Q, DuPont P, Demyttenaere K, Janssens J, Tack J. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology 2005;129:1437-1444.
Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833.
Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006;130:1447-1458.
O'Malley D, Dinan TG, Cryan JF. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides 2010;31:662-670.
Gosselin R, O'Connor RM, Tramullas M, JulioPieper M, Dinan TG, Cryan JF. Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms. Gastroenterology 2010;138:2418-2425.
Paykel ES. Life events, social support and depression. Acta Psychiatr Scand 1994;89:50-58.
Michalak EE, Wilkinson C, Hood K, Dowrick C, Wilkinson G. Seasonality, negative life events and social support in a community sample. Br J Psychiatry 2003;182:434-438.
Mikolajczak M, Roy E, Luminet O, De Timary P. Resilience and hypothalamic-pituitary-adrenal axis reactivity under acute stress in young men. Stress 2008;11:477-482.
Gupta A, Love A, Kilpatrick LA, Labus JS, Bhatt R, Chang L, Tillisch K, Naliboff B, Mayer EA. Morphological brain measures of cortico-limbic inhibition related to resilience. J Neurosci Res 2017;95:1760-1775.
Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140:761-765.
Chang L, Sundaresh S, Elliott J, Anton P, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff B. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. J Neurogastroenterol Motil 2009;21:149-159.
Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998;42:845-849.
Wilhelmsen I. Somatization, sensitization, and functional dyspepsia. Scand J Psychol 2002;43:177-180.
Lembo T, Naliboff B, Munakata J, Fullerton S, Saba L, Tung S, Schmulson M, Mayer EA. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320.
Creed F, Ratcliffe J, Fernandes L, Palmer S, Rigby C, Tomenson B, Guthrie E, Read N, Thompson DG. Outcome in severe irritable bowel syndrome with and without accompanying depressive, panic and neurasthenic disorders. Br J Psychiatry 2005;186:507-515.
Mikolajczak M, Roy E, Luminet O, de Timary P. Resilience and hypothalamic-pituitary-adrenal axis reactivity under acute stress in young men. Stress 2008;11:477-482.
Delany C, Miller K, ElAnsary D, Remedios L, Hosseini A, McLeod S. Replacing stressful challenges with positive coping strategies: a resilience program for clinical placement learning. Adv Health Sci Educ Theory Pract 2015;20:1303-1324.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.